Oxacyclohexadeca-3,11,13-triene-2,10-dione,15-[[(6-deoxy-b-D-allopyranosyl)oxy]methyl]-16-ethyl-15-hydroxy-5,7,9-trimethyl-6-[[3,4,6-trideoxy-3-(dimethylamino)-b-D-xylo-hexopyranosyl]oxy]-,(3E,5S,6S,7S,9R,11E,13E,15S,16R)- (9CI)
| Product Information | |
|---|---|
| Product Number: | AX-ADY9 |
| Product Name: | Oxacyclohexadeca-3,11,13-triene-2,10-dione,15-[[(6-deoxy-b-D-allopyranosyl)oxy]methyl]-16-ethyl-15-hydroxy-5,7,9-trimethyl-6-[[3,4,6-trideoxy-3-(dimethylamino)-b-D-xylo-hexopyranosyl]oxy]-,(3E,5S,6S,7S,9R,11E,13E,15S,16R)- (9CI) |
| CAS: | 129046-68-0 |
| MW: | |
| Synonyms: | MycinamicinI, 12,13-deepoxy-12,13-didehydro-2B,3B-di-O-demethyl-14-hydroxy-;Oxacyclohexadecane, mycinamicin I deriv.; Mycinamicin XV; Mycinamycin XV |
| EINECS: | |
| Density: | |
| Melting Point: | |
| Boiling Point: | |
| Flash Point: | |
| Solubility: | |
| Risk Codes: | |
| Transport Information:: | |